|
Braaten Health’s AD/HD Assessment Center is proud to introduce the
NeuroLexsm
Indicator Report Service as an aid in the assessment of AD/HD. NeuroLexsm
is a breakthrough, patent pending service that is built on the
convergence of proven technologies for transporting, processing, and
analyzing EEG data. It includes world class, regulatory compliant data
management and security services.
Used in
conjunction with current subjective tools available today (i.e. family
history, classroom history, and assessment scales), it empowers the
judgment of the physician and provides the comfort and assurance of
objectivity to the patient. NeuroLexsm
uses EEG as a method of obtaining biological, brainwave data from
patients in a safe, non-invasive procedure to provide reliable and
reproducible results.
To learn
more, contact Penny Grunder at 309-762-2998 or toll free at
866-235-6763. |
"The
NeuroLex AD/HD Indicator Report offers clinicians a quantitative measure
of AD/HD instead of the more subjective rating scales. It is an
excellent, reliable, sensitive and specific evaluation."
-Edward M. Hallowell, MD
Best selling author of Driven to Distraction
"Many of
my patients have been to several previous physicians only to be through
treatments with poor results. Patients are delighted that I am able to
provide a thorough investigation of their conditions or the disorders of
their children using high technology. The NeuroLex Report has enabled me
to take the guesswork out of evaluating patients, and as a result,
patients are more likely to comply with treatment given."
-Azmi Farag, MD
Board Certified Family Practice |
